LAB
Standard BioTools Inc.
$1.40
$0.00(0.00%)
41
Overall
--
Value
41
Tech
--
Quality
Market Cap
$534.79M
Volume
575.00K
52W Range
$0.92 - $2.32
Target Price
$1.78
Order:
Income Statement
| Metric | Trend | Chart | 2015 Dec | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||
| Total Revenue | $114.7M | $104.4M | $101.9M | $113.0M | $117.2M | $138.1M | $130.6M | $97.9M | $106.3M | $174.4M | ||
| Total Revenue | $114.7M | $104.4M | $101.9M | $113.0M | $117.2M | $138.1M | $130.6M | $97.9M | $106.3M | $174.4M | ||
| COST OF GOODS SOLD | ||||||||||||
| Cost of Revenue | $-3.6M | $-4.9M | $-50.0M | $-6.5M | $45.5M | $54.8M | $61.2M | $60.9M | $55.9M | $90.2M | ||
| GROSS PROFIT | ||||||||||||
| Gross Profit | $72.1M | $58.4M | $52.0M | $61.6M | $71.8M | $83.3M | $69.4M | $37.1M | $50.5M | $84.3M | ||
| OPERATING EXPENSES | ||||||||||||
| Operating Expenses | $122.2M | $-131.6M | $-110.3M | $-161.1M | $169.1M | $189.2M | $198.0M | $139.7M | $127.0M | $259.5M | ||
| Research & Development | $39.3M | $38.4M | $30.8M | $30.0M | $31.6M | $36.5M | $37.9M | $37.4M | $25.9M | $62.4M | ||
| Research Expense | $39.3M | $38.4M | $30.8M | $30.0M | $31.6M | $36.5M | $37.9M | $37.4M | $25.9M | $62.4M | ||
| Selling, General & Administrative | $83.0M | $93.2M | $79.5M | $79.8M | $84.5M | $97.9M | $98.9M | $102.3M | $87.5M | $156.6M | ||
| Selling & Marketing Expenses | $83.0M | $93.2M | $79.5M | $79.8M | $3.4M | $1.6M | $3.4M | $3.9M | $2.0M | $5.9M | ||
| General & Administrative Expenses | $-5.2M | $-6.3M | $-4.7M | $-5.0M | $84.5M | $97.9M | $98.9M | $102.3M | $87.5M | $156.6M | ||
| Promotion & Advertising | $-2.9M | $-2.3M | $-1.8M | $-2.2M | $3.4M | $1.6M | $3.4M | $3.9M | $2.0M | $5.9M | ||
| Salaries & Wages | $-514.0K | $-13.9M | $-9.1M | $-11.0M | -- | $300.0K | -- | $14.9M | $13.1M | $31.7M | ||
| Depreciation & Amortization | $-3.6M | $-5.1M | $-5.9M | $-4.2M | $3.6M | $3.1M | $3.2M | $12.5M | $3.4M | $12.3M | ||
| Depreciation & Amortization | $-3.6M | $-5.1M | $-5.9M | $-4.2M | $3.6M | $3.1M | $3.2M | $12.5M | $3.4M | $12.3M | ||
| Amortization | $-11.2M | $-11.2M | $-11.2M | $-11.2M | $104.1M | $106.6M | $106.4M | $106.3M | $106.3M | $111.3M | ||
| Other Operating Expenses | $-1.0M | $-1.7M | $-61.0K | $-255.0K | $-354.0K | $-441.0K | $-325.0K | $10.9M | $127.0M | $-2.7M | ||
| OPERATING INCOME | ||||||||||||
| Operating income | $-50.2M | $-73.2M | $-58.4M | $-48.2M | $-51.8M | $-51.0M | $-67.5M | $-116.2M | $-76.6M | $-175.2M | ||
| EBITDA | $-43.3M | $-68.7M | $-52.3M | $-27.9M | $-49.8M | $-34.6M | $-44.3M | $-176.2M | $-63.0M | $-134.0M | ||
| NON-OPERATING ITEMS | ||||||||||||
| Interest Expense (Non-Operating) | $5.8M | $5.8M | $5.8M | $13.9M | $4.3M | $3.6M | $3.8M | $4.3M | $4.6M | -- | ||
| Interest Income Operating | -- | -- | -- | -- | -- | -- | -- | -- | $5.6M | $20.2M | ||
| Net Non-Operating Interest Income/Expense | $-5.8M | $-5.8M | $-5.8M | $-13.9M | $-4.3M | $-3.6M | $-3.8M | $-4.3M | $-4.6M | -- | ||
| Gain on Sale of Securities | $2.3M | -- | -- | -- | -- | -- | -- | $-13.7M | -- | -- | ||
| Other Income/Expense | $-1.2M | $1.2M | $-385.0K | $-637.0K | $10.6M | $-507.0K | $-482.0K | $-86.0M | $-1.4M | $-20.0M | ||
| Other Special Charges | $-1.2M | $-1.2M | $385.0K | $637.0K | $-10.6M | $507.0K | $482.0K | $1.4M | $1.4M | $-5.2M | ||
| SPECIAL ITEMS | ||||||||||||
| Restructring And Mn A Income | -- | -- | -- | -- | -- | -- | -- | $9.7M | $7.1M | $12.5M | ||
| Special Income Charges | -- | -- | -- | -- | -- | -- | -- | $-9.7M | $-7.1M | $-12.5M | ||
| Impairment of Capital Assets | -- | -- | -- | -- | -- | -- | -- | $3.5M | -- | -- | ||
| PRE-TAX INCOME | ||||||||||||
| EBIT | $-54.5M | $-79.9M | $-63.5M | $-47.5M | $-62.4M | $-50.5M | $-59.8M | $-188.6M | $-74.2M | $-138.3M | ||
| Pre-Tax Income | $-54.8M | $-80.2M | $-63.8M | $-61.4M | $-66.7M | $-54.1M | $-63.7M | $-192.9M | $-74.2M | $-138.3M | ||
| INCOME TAX | ||||||||||||
| Tax Provision | $-1.5M | $-4.2M | $-3.3M | $-2.4M | $-1.9M | $-1.1M | $-4.4M | $-2.8M | $452.0K | $573.0K | ||
| NET INCOME | ||||||||||||
| Net Income | $-53.3M | $-76.0M | $-60.5M | $-59.0M | $-64.8M | $-53.0M | $-59.2M | $-190.1M | $-74.7M | $-138.9M | ||
| Net Income (Continuing Operations) | $-53.3M | $-76.0M | $-60.5M | $-59.0M | $-64.8M | $-53.0M | $-59.2M | $-190.1M | $-74.7M | $-138.9M | ||
| Net Income (Discontinued Operations) | $-53.3M | $-76.0M | $-60.5M | $-59.0M | $-64.8M | $-53.0M | $-59.2M | $-190.1M | $-74.7M | $-138.9M | ||
| Net Income (Common Stockholders) | $-53.3M | $-76.0M | $-60.5M | $-59.0M | $-64.8M | $-53.0M | $-59.2M | $-190.1M | $-74.7M | $-184.9M | ||
| Normalized Income | -- | -- | -- | -- | -- | -- | $-68.1M | -- | -- | $-121.7M | ||
| TOTALS | ||||||||||||
| Total Expenses | $118.6M | $-136.5M | $-160.3M | $-167.6M | $214.5M | $236.7M | $251.4M | $200.6M | $182.9M | $349.7M | ||
| SHARE & EPS DATA | ||||||||||||
| Average Shares Outstanding | $28.7M | $29.0M | $33.0M | $39.7M | $66.8M | $72.0M | $75.8M | $78.3M | $79.2M | $353.2M | ||
| Average Shares Outstanding (Diluted) | $28.7M | $29.0M | $32.9M | $39.6M | $66.8M | $72.0M | $75.8M | $78.3M | $79.2M | $353.2M | ||
| Shares Outstanding | $28.8M | $29.2M | $38.8M | $69.0M | $70.4M | $74.5M | $77.2M | $79.1M | $290.1M | $379.0M | ||
| Basic EPS | -- | -- | -- | -- | $-0.97 | $-0.74 | $-0.78 | $-2.43 | $-0.94 | $-0.52 | ||
| Basic EPS (Continuing Operations) | -- | -- | -- | -- | $-0.97 | $-0.74 | $-0.78 | $-2.43 | $-0.94 | $-0.52 | ||
| Diluted EPS | $-1.86 | $-2.62 | $-1.84 | $-1.49 | $-0.97 | $-0.74 | $-0.78 | $-2.43 | $-0.94 | $-0.52 | ||
| Diluted EPS (Continuing Operations) | -- | -- | -- | -- | -- | -- | $-0.78 | $-2.43 | $-0.94 | $-0.52 | ||
| OTHER METRICS | ||||||||||||
| Accrued Preferred Stock Dividends | -- | -- | -- | -- | -- | -- | -- | -- | -- | $46.0M | ||
| Acquisition Expense | -- | -- | -- | -- | -- | -- | -- | $3.9M | $6.5M | $28.0M | ||
| Interest Expense Operating | $-5.5M | $-5.5M | $-5.5M | -- | -- | -- | -- | -- | -- | -- | ||
| Other Gand A | $-5.2M | $-6.3M | $-4.7M | $-5.0M | $84.5M | $97.9M | $98.9M | $102.3M | $87.5M | $156.6M | ||
| Other Write Off | $-40.0K | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Otherunder Preferred Stock Dividend | -- | -- | -- | -- | -- | -- | -- | -- | -- | $46.0M | ||
| Preferred Stock Dividends | -- | -- | -- | -- | -- | -- | -- | -- | -- | $46.0M | ||
| Rent And Landing Fees | $-5.2M | $-6.3M | $-4.7M | $-5.0M | -- | -- | -- | -- | -- | -- | ||
| Selling Expense | $83.0M | $93.2M | $79.5M | $79.8M | -- | -- | -- | -- | -- | -- | ||
| Restruct | -- | -- | -- | -- | -- | -- | -- | $9.7M | $7.1M | $12.5M | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | LAB | $1.40 | 0% | 575.00K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |